CLINICAL CASE OF DELAYED TREATMENT OF VISCERAL LEISCHMANIASIS

Authors

  • Anvarov Jakhongir Abralovich,Sherbekova Diyora Ulug’bek qizi ,Norqizilova Gulira’no Olim qizi Author

Keywords:

visceral leishmaniasis, L. infantum, diagnosis, Sol. meglumine antimonate.

Abstract

This article provides brief information about the etiology, epidemiology, clinical picture, diagnosis and etiotropic therapy of visceral leishmaniasis. Also, the article presents a clinical case of Mediterranean-Central Asian (childhood) visceral leishmaniasis in a 5-year-old boy. The development of the clinical picture of the disease, laboratory and instrumental research methods are described in detail. For the purpose of etiotropic therapy, the patient was prescribed Sol. Meglumine antimonate (Glucantim) according to a regimen that gave a good therapeutic effect.

References

Leishmaniasis https://www.who.int/ru/news-room/fact-sheets/detail/ leishmaniasis. January 8, 2022

Luigi Gradoni, Rogelio López-Vélez, Mourad Mokni. Guidelines for case management and surveillance of leishmaniasis in the WHO European Region. World Health Organization, 2018. 84 pp.

J. A. R. Postigo, “Leishmaniasis in the world health organization eastern mediterranean region,” International Journal of Antimicrobial Agents, vol. 36, no. 1, pp. S62–S65, 2010.

WHO “Working to overcome the global impact of neglected tropical diseases: frst WHO report on neglected tropical diseases, 2010”

Infectious diseases with childhood infections // Edited by Academician of the Academy of Sciences of the Republic of Uzbekistan Daminov T.A., textbook, 2nd volume, Tashkent, “Tib-Kitob” 2010 - 272 p.

Human parasitic diseases (protozooses and helminthiases) / edited by V.P. Sergieva, Yu.V. Lobzina, S.S. Kozlova. – St. Petersburg: Foliant, 2011. – 607 p.

Bogadelnikov I.V., Lagunova N.V., Lukyanets L.V., Syurina A.N., Kruger E.A. Visceral leishmaniasis: clinical case // Child’s Health, No. 3 (54). 2014. pp. 124-127.

Akhmedova M.D., Tashpulatova Sh.A., Anvarov Zh.A., Imamova I.A. Gaibullaev F.Kh. Predictors of severe course of visceral leishmaniasis // Ontustik Kazakhstan Medicine Academies Khabarshysy No. 1-2 (82) 2018, 2018. pp. 36-40.

Gradoni L, Soteriadou K, Louzir H, Dakkak A, Toz SO, Jaffe C et al. Drug regimens for visceral leishmaniasis in Mediterranean countries. Trop Med Int Health. 2008;13:1272–6,

Petrela R, Kuneshka L, Foto E, Zavalani F, Gradoni L. Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1210 consecutive hospitalized patients (1995–2009). PLoS Negl Trop Dis. 2010;4:e814.

Fight against leishmaniasis. Report to the meeting of the WHO Expert Committee on the Control of Leishmaniasis, Geneva, 22–26 March 2010. Geneva: World Health Organization; 2010 (WHO Technical Report Series, No. 949).

Published

2024-05-01